On December 12, 2023, the MAPS Public Benefit Corporation (MAPS PBC) announced the submission of a marketing application to the U.S. Food and Drug Administration (FDA) for MDMA (midomafetamine capsules) in combination with psychological...
In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold.
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide mental health benefits, including coverage for substance use disorders (SUDs), that are in “parity” with medical and surgical benefits. The...
On July 31, 2023, the Centers for Medicare & Medicaid Services (CMS) announced a new eight-year voluntary nationwide model – the Guiding an Improved Dementia Experience (GUIDE) Model that aims to support people living with dementia and...
Last week, a Ninth Circuit panel vacated its prior decision in the long-running Wit v. United Behavioral Health litigation and issued a new opinion.
COVID-19 was accompanied by serious disruptions in care and treatment for persons with OUD, as well as isolation, loneliness, grief, job loss, and economic and housing instability.
Last week, the departments of the Treasury, Labor and Health and Human Services (collectively, the Departments) published long-awaited proposed regulations intended to clarify and improve compliance with the federal mental health parity law known...
Catalyzed by the COVID-19 pandemic, many behavioral health care providers have implemented telehealth services to augment existing partial hospitalization programs and intensive outpatient programs.
The Ninth Circuit has issued a new opinion in the long-running Wit v. United Behavioral Health litigation that changes the legal landscape for ERISA class actions.
Catalyzed by the COVID-19 pandemic, many behavioral health care providers implemented telehealth services to augment existing partial hospitalization programs and intensive outpatient programs.